{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T20:20:50Z","timestamp":1780345250531,"version":"3.54.1"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R21MH113455"],"award-info":[{"award-number":["R21MH113455"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI129745 , R01AI134245"],"award-info":[{"award-number":["R01 AI129745 , R01AI134245"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA052845"],"award-info":[{"award-number":["DA052845"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Despite advances in combination antiretroviral therapy (cART), people living with HIV (PLWH) continue to experience gastrointestinal dysfunction. Infusions of anti-\u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>7<\/jats:sub> monoclonal antibodies (mAbs) have been proposed to increase virologic control during simian immunodeficiency virus (SIV) infection in macaques with mixed results. Recent evidences suggested that therapeutic efficacy of vedolizumab (a humanized anti-\u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>7<\/jats:sub> mAb), during inflammatory bowel diseases depends on microbiome composition, myeloid cell differentiation, and macrophage phenotype. We tested this hypothesis in SIV-infected, anti-\u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>7<\/jats:sub> mAb-treated macaques and provide flow cytometric and microscopic evidence that anti-\u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>7<\/jats:sub> administered to SIV-infected macaques increases the maturity of macrophage phenotypes typically lost in the small intestines during SIV disease progression. Further, this increase in mature macrophage phenotype was associated with tissue viral loads. These phenotypes were also associated with dysbiosis markers in the gut previously identified as predictors of HIV replication and immune activation in PLWH. These findings provide a novel model of anti-\u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>7<\/jats:sub> efficacy offering new avenues for targeting pathogenic mucosal immune response during HIV\/SIV infection.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1001727","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T06:10:00Z","timestamp":1667283000000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Early treatment with anti-\u03b14\u03b27 antibody facilitates increased gut macrophage maturity in SIV-infected rhesus macaques"],"prefix":"10.3389","volume":"13","author":[{"given":"Samuel D.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omalla A.","family":"Olwenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michellie","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddappa N.","family":"Byrareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw258","article-title":"Gut mucosal barrier dysfunction, microbial dysbiosis, and their role in HIV-1 disease progression","volume":"214","author":"Mudd","year":"2016","journal-title":"J Infect Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.07.027","article-title":"Inflammatory and immunometabolic consequences of gut dysfunction in HIV: Parallels with IBD and implications for reservoir persistence and non-AIDS comorbidities","volume":"46","author":"Alzahrani","year":"2019","journal-title":"EBioMedicine"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-2882-6.50027-7","article-title":"Gastrointestinal disorders in HIV","author":"Serlin","year":"2008","journal-title":"Global HIV\/AIDS Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2019.03.018","article-title":"Symptom clusters in people living with HIV: A systematic review","volume":"58","author":"Zhu","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2217\/imt.12.85","article-title":"Vedolizumab for the treatment of ulcerative colitis and crohn's disease","volume":"4","author":"McLean","year":"2012","journal-title":"Immunotherapy"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402866","article-title":"Species-specific differences in the expression and regulation of \u03b14\u03b27 integrin in various nonhuman primates","volume":"194","author":"Byrareddy","year":"2015","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2009.06.012","article-title":"Preliminary in vivo efficacy studies of a recombinant rhesus anti-\u03b14\u03b27 monoclonal antibody","volume":"259","author":"Pereira","year":"2009","journal-title":"Cell Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.aag1276","article-title":"Sustained virologic control in SIV+ macaques after antiretroviral and \u03b14\u03b27 antibody therapy","volume":"354","author":"Byrareddy Siddappa","year":"2016","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3715","article-title":"Targeting \u03b14\u03b27 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection","volume":"20","author":"Byrareddy","year":"2014","journal-title":"Nat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau4711","article-title":"Anti-\u03b14\u03b27 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1\u2013infected individuals","volume":"10","author":"Uzzan","year":"2018","journal-title":"Sci Trans Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw8562","article-title":"Lack of therapeutic efficacy of an antibody to \u03b14\u03b27 in SIVmac251-infected rhesus macaques","volume":"365","author":"Abbink","year":"2019","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav6695","article-title":"Evaluation of an antibody to \u03b14\u03b27 in the control of SIVmac239-nef-stop infection","volume":"365","author":"Di Mascio","year":"2019","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e21282","DOI":"10.1096\/fj.202002235R","article-title":"Mucosal integrin \u03b14\u03b27 blockade fails to reduce the seeding and size of viral reservoirs in SIV-infected rhesus macaques","volume":"35","author":"Ziani","year":"2021","journal-title":"FASEB J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax3447","article-title":"An open-label phase 1 clinical trial of the anti-\u03b14\u03b27 monoclonal antibody vedolizumab in HIV-infected individuals","volume":"11","author":"Sneller","year":"2019","journal-title":"Sci Transl Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf7201","article-title":"Blocking \u03b14\u03b27 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies","volume":"13","author":"Frank","year":"2021","journal-title":"Sci Trans Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.612830","article-title":"Vedolizumab: Potential mechanisms of action for reducing pathological inflammation in inflammatory bowel diseases","volume":"9","author":"Luzentales-Simpson","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/gutjnl-2018-316023","article-title":"Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease","volume":"68","author":"Zeissig","year":"2019","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000002874","article-title":"Comparison of predictors for terminal disease progression in simian immunodeficiency virus\/simian-HIV-infected rhesus macaques","volume":"35","author":"Takahashi","year":"2021","journal-title":"AIDS"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801457","article-title":"Shifting dynamics of intestinal macrophages during simian immunodeficiency virus infection in adult rhesus macaques","volume":"202","author":"Takahashi","year":"2019","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1038\/s41598-021-88823-2","article-title":"Evaluation of changes in intestinal microbiota in crohn\u2019s disease patients after anti-TNF alpha treatment","volume":"11","author":"Sanchis-Artero","year":"2021","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/gutjnl-2020-321106","article-title":"Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study","volume":"70","author":"Clooney","year":"2021","journal-title":"Gut"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20903","article-title":"Low counts of faecalibacterium prausnitzii in colitis microbiota","volume":"15","author":"Sokol","year":"2009","journal-title":"Inflammatory Bowel Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.757718","article-title":"Roseburia intestinalis: A beneficial gut organism from the discoveries in genus and species","volume":"11","author":"Nie","year":"2021","journal-title":"Front Cell Infection Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001366","article-title":"Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation","volume":"31","author":"Dillon","year":"2017","journal-title":"AIDS"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.01104","article-title":"Gut microbiome alterations during HIV\/SIV infection: Implications for HIV cure","volume":"10","author":"Crakes","year":"2019","journal-title":"Front Microbiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009031","article-title":"Mechanistic basis of post-treatment control of SIV after anti-\u03b14\u03b27 antibody therapy","volume":"17","author":"Wells","year":"2021","journal-title":"PloS Comput Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170057","article-title":"Transcriptional and functional profiling defines human small intestinal macrophage subsets","volume":"215","author":"Bujko","year":"2017","journal-title":"J Exp Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01657-20","article-title":"Chronic morphine administration differentially modulates viral reservoirs in a simian immunodeficiency virus SIVmac251-infected rhesus macaque model","volume":"95","author":"Acharya","year":"2020","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.1038\/s41598-018-21882-0","article-title":"Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assay","volume":"8","author":"Dyavar","year":"2018","journal-title":"Sci Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J Microscopy"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.82","article-title":"\u03b27-integrin exacerbates experimental DSS-induced colitis in mice by directing inflammatory monocytes into the colon","volume":"9","author":"Schippers","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clim.2014.11.005","article-title":"Localization of dendritic cells in the gut epithelium requires MAdCAM-1","volume":"156","author":"Clahsen","year":"2015","journal-title":"Clin Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fmicb.2020.01065","article-title":"The relationship between gut microbiota and inflammatory diseases: The role of macrophages","volume":"2020","author":"Wang","year":"1065","journal-title":"Front Microbiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.chom.2017.04.010","article-title":"Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases","volume":"21","author":"Ananthakrishnan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.03236-19","article-title":"Respiratory viral infection alters the gut microbiota by inducing inappetence","volume":"11","author":"Groves","year":"2020","journal-title":"mBio"},{"key":"B37","doi-asserted-by":"publisher","first-page":"17679","DOI":"10.1038\/s41598-018-35877-4","article-title":"High abundance of genus prevotella in the gut of perinatally HIV-infected children is associated with IP-10 levels despite therapy","volume":"8","author":"Kaur","year":"2018","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"19056","DOI":"10.1038\/s41598-020-76145-8","article-title":"Alterations of the gut bacterial microbiota in rhesus macaques with SIV infection and on short- or long-term antiretroviral therapy","volume":"10","author":"Siddiqui","year":"2020","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"crossref","first-page":"e1003829","DOI":"10.1371\/journal.ppat.1003829","article-title":"A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects","volume":"10","author":"Mutlu","year":"2014","journal-title":"PloS Pathog"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02764","article-title":"Dynamics of colon monocyte and macrophage activation during colitis","volume":"9","author":"Jones","year":"2018","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.4049\/jimmunol.167.5.2651","article-title":"Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities","volume":"167","author":"Smith","year":"2001","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000384","article-title":"Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD","volume":"21","author":"Lissner","year":"2015","journal-title":"Inflammatory bowel Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1136\/gutjnl-2019-318264","article-title":"Anti-TNF therapy in IBD exerts its therapeutic effect through macrophage IL-10 signalling","volume":"69","author":"Koelink","year":"2020","journal-title":"Gut"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI34610","article-title":"Unique CD14 intestinal macrophages contribute to the pathogenesis of crohn disease via IL-23\/IFN-gamma axis","volume":"118","author":"Kamada","year":"2008","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000824","article-title":"Role of monocytes and intestinal macrophages in crohn's disease and ulcerative colitis","volume":"22","author":"Gren","year":"2016","journal-title":"Inflammation Bowel Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201545738","article-title":"Macrophage accumulation in gut mucosa differentiates AIDS from chronic SIV infection in rhesus macaques","volume":"46","author":"Swan","year":"2016","journal-title":"Eur J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1126\/science.1217550","article-title":"Natural SIV hosts: Showing AIDS the door","volume":"335","author":"Chahroudi","year":"2012","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1038\/s41467-019-12987-9","article-title":"Macrophage-associated wound healing contributes to African green monkey SIV pathogenesis control","volume":"10","author":"Barrenas","year":"2019","journal-title":"Nat Commun"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41467-020-16222-8","article-title":"HIV-Associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases","volume":"11","author":"Vujkovic-Cvijin","year":"2020","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.01.032","article-title":"Gut microbiota linked to sexual preference and HIV infection","volume":"5","author":"Noguera-Julian","year":"2016","journal-title":"EBioMedicine"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.116","article-title":"An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia","volume":"7","author":"Dillon","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41385-020-0296-4","article-title":"Perturbation of the gut microbiome by prevotella spp. enhances host susceptibility to mucosal inflammation","volume":"14","author":"Iljazovic","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s40168-021-01168-w","article-title":"Signature changes in gut microbiome are associated with increased susceptibility to HIV-1 infection in MSM","volume":"9","author":"Chen","year":"2021","journal-title":"Microbiome"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-018-0029-0","article-title":"Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques","volume":"11","author":"Sui","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.3390\/cells10071775","article-title":"Butyrate and the intestinal epithelium: Modulation of proliferation and inflammation in homeostasis and disease","volume":"10","author":"Salvi","year":"2021","journal-title":"Cells"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.12.007","article-title":"Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis","volume":"40","author":"Singh","year":"2014","journal-title":"Immunity"},{"key":"B57","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2017.112","article-title":"Early treatment of SIV+ macaques with an \u03b14\u03b27 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection","volume":"11","author":"Santangelo","year":"2018","journal-title":"Mucosal Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmaa145","article-title":"Association of dietary fiber, fruit, and vegetable consumption with risk of inflammatory bowel disease: A systematic review and meta-analysis","volume":"12","author":"Milajerdi","year":"2021","journal-title":"Adv Nutr"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2015.52753","article-title":"The role of dietary fibre in inflammatory bowel disease","volume":"10","author":"Pituch-Zdanowska","year":"2015","journal-title":"Prz Gastroenterol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0085-3","article-title":"Resistance of HIV-infected macrophages to CD8+ T lymphocyte\u2013mediated killing drives activation of the immune system","volume":"19","author":"Clayton","year":"2018","journal-title":"Nat Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000504888","article-title":"SERINC5 is an unconventional HIV restriction factor that is upregulated during myeloid cell differentiation","volume":"12","author":"Zutz","year":"2020","journal-title":"J Innate Immun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virol.2014.03.024","article-title":"Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques","author":"Yen","year":"2014","journal-title":"Virology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/QAD.0000000000002429","article-title":"In-vivo use of SIVmac239 with a reversing stop codon in the SIV nef gene","volume":"34","author":"Villinger","year":"2020","journal-title":"AIDS"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aam7341","article-title":"Virion incorporation of integrin \u03b14\u03b27 facilitates HIV-1 infection and intestinal homing","volume":"2","author":"Guzzo","year":"2017","journal-title":"Sci Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf7201","article-title":"Blocking \u03b14\u03b27 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies","volume":"13","author":"Frank","year":"2021","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw7765","article-title":"Blocking \u03b14\u03b27 integrin binding to SIV does not improve virologic control","volume":"365","author":"Iwamoto","year":"2019","journal-title":"Science"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2018.08.041","article-title":"Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features","volume":"174","author":"Zmora","year":"2018","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1044711","article-title":"High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals","volume":"6","author":"Ringel","year":"2015","journal-title":"Gut Microbes"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1001727\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T06:10:04Z","timestamp":1667283004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1001727\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2022.1001727"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1001727","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"article-number":"1001727"}}